Hay CR - Search Results

1

Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.

Collins PW, Chalmers E, Hart DP, Liesner R, Rangarajan S, Talks K, Williams M, Hay CR; UK Haemophilia Centre Doctors. Collins PW, et al. Among authors: hay cr. Br J Haematol. 2013 Jan;160(2):153-70. doi: 10.1111/bjh.12091. Epub 2012 Nov 15. Br J Haematol. 2013. PMID: 23157203 Free article. No abstract available.

2

The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO).

Hay CR, Baglin TP, Collins PW, Hill FG, Keeling DM. Hay CR, et al. Br J Haematol. 2000 Oct;111(1):78-90. doi: 10.1046/j.1365-2141.2000.02327.x. Br J Haematol. 2000. PMID: 11091185 Free article. No abstract available.

3

Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII: plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleeding.

Smith MP, Ludlam CA, Collins PW, Hay CR, Wilde JT, Grigeri A, Melsen T, Savidge GF. Smith MP, et al. Among authors: hay cr. Thromb Haemost. 2001 Oct;86(4):949-53. Thromb Haemost. 2001. PMID: 11686351 Clinical Trial.

4

Pharmacokinetics of recombinant factor VIII (recombinate) using one-stage clotting and chromogenic factor VIII assay.

Lee CA, Owens D, Bray G, Giangrande P, Collins P, Hay C, Gomperts E, Schroth P, Barrowcliffe T. Lee CA, et al. Thromb Haemost. 1999 Dec;82(6):1644-7. Thromb Haemost. 1999. PMID: 10613649 Clinical Trial.

5

Why do inhibitors arise in patients with haemophilia A?

Hay CR. Hay CR. Br J Haematol. 1999 Jun;105(3):584-90. doi: 10.1046/j.1365-2141.1999.01396.x. Br J Haematol. 1999. PMID: 10354116 Free article. Review. No abstract available.

6

The incidence of factor VIII inhibitors in the United Kingdom, 1990-93. Inhibitor Working Party. United Kingdom Haemophilia Centre Directors Organization.

Colvin BT, Hay CR, Hill FG, Preston FE. Colvin BT, et al. Among authors: hay cr. Br J Haematol. 1995 Apr;89(4):908-10. doi: 10.1111/j.1365-2141.1995.tb08435.x. Br J Haematol. 1995. PMID: 7772532

7

Comparative pharmacokinetics of plasma- and albumin-free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age-related differences and implications for dose tailoring.

Björkman S, Blanchette VS, Fischer K, Oh M, Spotts G, Schroth P, Fritsch S, Patrone L, Ewenstein BM; Advate Clinical Program Group; Collins PW. Björkman S, et al. J Thromb Haemost. 2010 Apr;8(4):730-6. doi: 10.1111/j.1538-7836.2010.03757.x. J Thromb Haemost. 2010. PMID: 20398185 Free PMC article.

8

Novel, human cell line-derived recombinant factor VIII (human-cl rhFVIII; Nuwiq^® ) in adults with severe haemophilia A: efficacy and safety.

Lissitchkov T, Hampton K, von Depka M, Hay C, Rangarajan S, Tuddenham E, Holstein K, Huth-Kühne A, Pabinger I, Knaub S, Bichler J, Oldenburg J. Lissitchkov T, et al. Haemophilia. 2016 Mar;22(2):225-231. doi: 10.1111/hae.12793. Epub 2015 Aug 28. Haemophilia. 2016. PMID: 26315974

9

Acquired haemophilia.

Hay CR. Hay CR. Baillieres Clin Haematol. 1998 Jun;11(2):287-303. doi: 10.1016/s0950-3536(98)80049-8. Baillieres Clin Haematol. 1998. PMID: 10097808 Review.

10

Recommendations for the treatment of factor VIII inhibitors: from the UK Haemophilia Centre Directors' Organisation Inhibitor Working Party.

Hay CR, Colvin BT, Ludlam CA, Hill FG, Preston FE. Hay CR, et al. Blood Coagul Fibrinolysis. 1996 Mar;7(2):134-8. Blood Coagul Fibrinolysis. 1996. PMID: 8735802

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

154 results

Search Page